Physicians struggle to identify which patients are likely to respond to a recently approved therapy. Cancerous cell growth (orange) in the colon. A landmark cancer drug approved last year seemed to herald a long-anticipated change in the treatment of some tumours: with medicines selected on the basis of molecular markers, rather than the tissue in...